AI assistant
KALA BIO, Inc. — Director's Dealing 2022
May 25, 2022
35091_dirs_2022-05-25_2f216ee8-4676-478a-8ac6-f11055c4e40e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Kala Pharmaceuticals, Inc. (KALA)
CIK: 0001479419
Period of Report: 2022-05-23
Reporting Person: RA CAPITAL MANAGEMENT, L.P. (10% Owner)
Reporting Person: RA Capital Healthcare Fund LP (10% Owner)
Reporting Person: Kolchinsky Peter (10% Owner)
Reporting Person: Shah Rajeev M. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-23 | Common Stock | S | 1250000 | $0.65 | Disposed | 9624613 | Indirect |
| 2022-05-24 | Common Stock | S | 144805 | $0.51 | Disposed | 9479808 | Indirect |
| 2022-05-25 | Common Stock | S | 1434509 | $0.42 | Disposed | 8045299 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $0.60 to $0.72; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected upon request to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
F2: These securities include 9,624,613 shares held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3: This transaction was executed in multiple trades at prices ranging from $0.50 to $0.55, the price reported above reflects the weighted average sale price.
F4: These securities include 9,479,808 shares held directly by the Fund.
F5: This transaction was executed in multiple trades at prices ranging from $0.40 to $0.52; the price reported above reflects the weighted average sale price.
F6: These securities include 8,045,299 shares held directly by the Fund.
F7: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.